At RECORNEA we reinstate optimal vision in 15+ M patients suffering of Keratoconus, a progressive eye disease causing distorted vision.
Both current ocular surgeries and devices are not effective in reinstating a predictable, uniform and stable-in-time shape of the cornea leading to a very poor quality of vision and life for these patients.
We develop the GROSSO® Implant, the first corneal metal implant to restore the physiological curvature of the cornea with clear and predictable clinical outcomes. Product and production process fully defined and ready to start the Clinical Trials.
Emiliano Lepore
has a PhD in structural engineering with 10 years experience in innovation and business development in medtech and biotech. Emiliano has co-invented and is a co-owner of two licensed patents. He holds IP related to the device we are working on at RECORNEA.
Kakanga Moses
completed a PhD the National University of Singapore where he specialized in biotechnology and biosensor design. Moses has 10 + years in conducting clinical trials for both medical devices and bio-pharmaceuticals. He will be in charge of conducting clinical trials and product development.
Both current ocular surgeries and devices are not effective in reinstating a predictable, uniform and stable-in-time shape of the cornea leading to a very poor quality of vision and life for these patients.
We develop the GROSSO® Implant, the first corneal metal implant to restore the physiological curvature of the cornea with clear and predictable clinical outcomes. Product and production process fully defined and ready to start the Clinical Trials.
Emiliano Lepore
has a PhD in structural engineering with 10 years experience in innovation and business development in medtech and biotech. Emiliano has co-invented and is a co-owner of two licensed patents. He holds IP related to the device we are working on at RECORNEA.
Kakanga Moses
completed a PhD the National University of Singapore where he specialized in biotechnology and biosensor design. Moses has 10 + years in conducting clinical trials for both medical devices and bio-pharmaceuticals. He will be in charge of conducting clinical trials and product development.
Employees: 1-10
Founded date: 2019
Investors 2
| Date | Name | Website |
| 13.12.2021 | Health Wil... | healthwild... |
| - | Entreprene... | joinef.com |
Mentions in press and media 4
| Date | Title | Description |
| 09.07.2023 | Illuminating Italy’s Medical Device Innovators: Unveiling 15 Groundbreaking Startups Shaping Healthcare | Table of Contents show 1 MgShell: Advancing Treatment for Macular Degeneration 2 Wita: Empowering Healthcare Facilities with Technological Solutions 3 ElectroPhysiology Frontiers: Pioneering Pulmonary Vein Isolation 4 siHealth Photonics... |
| 10.09.2021 | StartUPDATES: New developments from healthcare startups | Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 millio... |
| - | StartUPDATES: New developments from healthcare startups | Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 millio... |
| - | Recornea | “Recornea technologies prevent blindness through proprietary technology that creates innovative minimally-invasive products for ophthalmic applications.” |